<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pazi MB</submitter><funding>IEPhB Research Program</funding><pagination>3951</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11011682</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(7)</volume><pubmed_abstract>The accumulation of misfolded and aggregated α-synuclein can trigger endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), leading to apoptotic cell death in patients with Parkinson's disease (PD). As the major ER chaperone, glucose-regulated protein 78 (GRP78/BiP/HSPA5) plays a key role in UPR regulation. GRP78 overexpression can modulate the UPR, block apoptosis, and promote the survival of nigral dopamine neurons in a rat model of α-synuclein pathology. Here, we explore the therapeutic potential of intranasal exogenous GRP78 for preventing or slowing PD-like neurodegeneration in a lactacystin-induced rat model. We show that intranasally-administered GRP78 rapidly enters the substantia nigra pars compacta (SNpc) and other afflicted brain regions. It is then internali</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Intranasal Administration of GRP78 Protein (HSPA5) Confers Neuroprotection in a Lactacystin-Induced Rat Model of Parkinson's Disease.</pubmed_title><pmcid>PMC11011682</pmcid><funding_grant_id>075-00264-24-00</funding_grant_id><pubmed_authors>Ekimova IV</pubmed_authors><pubmed_authors>Pazi MB</pubmed_authors><pubmed_authors>Belan DV</pubmed_authors><pubmed_authors>Komarova EY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intranasal Administration of GRP78 Protein (HSPA5) Confers Neuroprotection in a Lactacystin-Induced Rat Model of Parkinson's Disease.</name><description>The accumulation of misfolded and aggregated α-synuclein can trigger endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), leading to apoptotic cell death in patients with Parkinson's disease (PD). As the major ER chaperone, glucose-regulated protein 78 (GRP78/BiP/HSPA5) plays a key role in UPR regulation. GRP78 overexpression can modulate the UPR, block apoptosis, and promote the survival of nigral dopamine neurons in a rat model of α-synuclein pathology. Here, we explore the therapeutic potential of intranasal exogenous GRP78 for preventing or slowing PD-like neurodegeneration in a lactacystin-induced rat model. We show that intranasally-administered GRP78 rapidly enters the substantia nigra pars compacta (SNpc) and other afflicted brain regions. It is then internali</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-04T09:33:45.032Z</modification><creation>2025-04-04T09:33:45.032Z</creation></dates><accession>S-EPMC11011682</accession><cross_references><pubmed>38612761</pubmed><doi>10.3390/ijms25073951</doi></cross_references></HashMap>